Sign in
8-K/A

Current Report

NRX Pharmaceuticals, Inc. Filed Acc 0001104659-23-032019

Material agreement · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading tm239495d1_8ka.htm…